Innovative Eyewear (NASDAQ:LUCY – Get Free Report) and Sight Sciences (NASDAQ:SGHT – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, profitability, valuation and analyst recommendations.
Institutional & Insider Ownership
1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 55.5% of Sight Sciences shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by insiders. Comparatively, 30.4% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Valuation and Earnings
This table compares Innovative Eyewear and Sight Sciences”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Innovative Eyewear | $2.66 million | 2.91 | -$7.59 million | ($1.29) | -0.69 |
| Sight Sciences | $77.36 million | 6.35 | -$38.43 million | ($0.56) | -15.93 |
Innovative Eyewear has higher earnings, but lower revenue than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Innovative Eyewear and Sight Sciences, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
| Sight Sciences | 1 | 2 | 5 | 0 | 2.50 |
Sight Sciences has a consensus price target of $7.88, indicating a potential downside of 11.72%. Given Sight Sciences’ stronger consensus rating and higher probable upside, analysts clearly believe Sight Sciences is more favorable than Innovative Eyewear.
Volatility & Risk
Innovative Eyewear has a beta of 2.74, meaning that its share price is 174% more volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 2.45, meaning that its share price is 145% more volatile than the S&P 500.
Profitability
This table compares Innovative Eyewear and Sight Sciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Innovative Eyewear | -225.26% | -88.90% | -80.34% |
| Sight Sciences | -35.69% | -43.39% | -22.86% |
Summary
Sight Sciences beats Innovative Eyewear on 11 of the 14 factors compared between the two stocks.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
About Sight Sciences
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
Receive News & Ratings for Innovative Eyewear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovative Eyewear and related companies with MarketBeat.com's FREE daily email newsletter.
